Pages that link to "Q36844715"
Jump to navigation
Jump to search
The following pages link to The perfect mix: recent progress in adjuvant research (Q36844715):
Displaying 50 items.
- Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate (Q24288709) (← links)
- Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses (Q24624348) (← links)
- Adjuvants: Classification, Modus Operandi, and Licensing (Q26747586) (← links)
- Vaccine adjuvants as potential cancer immunotherapeutics (Q26752522) (← links)
- Plastids: The Green Frontiers for Vaccine Production (Q26774629) (← links)
- H5N1 vaccines in humans (Q27000896) (← links)
- Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification (Q27001592) (← links)
- Safety assessment of adjuvanted vaccines: Methodological considerations (Q27013956) (← links)
- Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens (Q27310007) (← links)
- Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques (Q27317212) (← links)
- Emulsified phosphatidylserine, simple and effective peptide carrier for induction of potent epitope-specific T cell responses (Q27332152) (← links)
- Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment (Q27346705) (← links)
- Vaccines: the Fourth Century (Q27490454) (← links)
- Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice (Q28727249) (← links)
- Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice (Q28730052) (← links)
- Defensins as anti-inflammatory compounds and mucosal adjuvants (Q28748926) (← links)
- Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands (Q28972540) (← links)
- Preclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines (Q30352121) (← links)
- Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection. (Q30368742) (← links)
- Molecular and cellular signatures of human vaccine adjuvants. (Q30370898) (← links)
- Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity. (Q30373740) (← links)
- Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. (Q30377447) (← links)
- Identification of a CD4 T-cell epitope in the hemagglutinin stalk domain of pandemic H1N1 influenza virus and its antigen-driven TCR usage signature in BALB/c mice (Q30387865) (← links)
- Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine (Q30400146) (← links)
- Pandemic influenza vaccines - the challenges (Q30408091) (← links)
- Improving defences at the portal of HIV entry: mucosal and innate immunity (Q30494738) (← links)
- Serum cytokine profiles associated with specific adjuvants used in a DNA prime-protein boost vaccination strategy (Q31138173) (← links)
- Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements (Q33367582) (← links)
- The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen (Q33451335) (← links)
- Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study (Q33588044) (← links)
- Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design. (Q33646948) (← links)
- Genetically modified organisms and visceral leishmaniasis (Q33647026) (← links)
- The Use of Xanthan Gum as Vaccine Adjuvant: An Evaluation of Immunostimulatory Potential in BALB/c Mice and Cytotoxicity In Vitro (Q33710401) (← links)
- Identification of peptide mimotopes of gp96 using single-chain antibody library (Q33720789) (← links)
- Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity. (Q33759392) (← links)
- Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4. (Q33759497) (← links)
- Dendritic Cell Dysfunction in Patients with End-stage Renal Disease (Q33835103) (← links)
- Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies (Q33890011) (← links)
- Antigen delivery by lipid-enveloped PLGA microparticle vaccines mediated by in situ vesicle shedding. (Q33972302) (← links)
- Recent progress in adjuvant discovery for peptide-based subunit vaccines (Q34033780) (← links)
- Laser vaccine adjuvant for cutaneous immunization (Q34046148) (← links)
- Design of lipid nanocapsule delivery vehicles for multivalent display of recombinant Env trimers in HIV vaccination (Q34074750) (← links)
- The role of mTOR in memory CD8 T-cell differentiation (Q34120067) (← links)
- Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients (Q34168451) (← links)
- Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus (Q34208783) (← links)
- Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis (Q34277331) (← links)
- Highly effective generic adjuvant systems for orphan or poverty-related vaccines (Q34307955) (← links)
- Biomaterials for nanoparticle vaccine delivery systems (Q34345012) (← links)
- Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model (Q34345467) (← links)
- Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach (Q34631422) (← links)